421 results match your criteria: "Andreas Sygros Hospital[Affiliation]"
Dermatol Ther (Heidelb)
March 2024
First Department of Dermatology and Venereology, Aristotle University of Thessaloniki, Hospital of Skin and Venereal Diseases, Thessaloniki, Greece.
J Clin Med
February 2024
2nd Department of Dermatology and Venereology, "Attikon" General University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
: Dermatoscopy has been established as an important diagnostic tool for a wide range of skin diseases. This study aims to evaluate the use of dermatoscopy in clinical practice among Greek dermatologists. : A nationwide questionnaire-based survey was conducted collecting data on the frequency of dermatoscopic examinations, the types of lesions examined, training and educational resources, as well as factors influencing the choice to incorporate dermatoscopy into daily clinical routines.
View Article and Find Full Text PDFIndian J Dermatol Venereol Leprol
January 2024
Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Faculty of Medicine, Andreas Sygros Hospital, Athens, Greece.
Dermatol Ther (Heidelb)
February 2024
Dermatology Department, University Hospital of Heraklion, 71110, Heraklion, Crete, Greece.
Dermatol Ther (Heidelb)
January 2024
University of Athens, Athens, Greece.
The skin microbiome consists of the microorganisms populating the human skin. Cutibacterium acnes (C. acnes, formerly named Propionibacterium acnes) is recognized as a key factor in acne development, regulating inflammatory and immune pathways.
View Article and Find Full Text PDFJ Am Acad Dermatol
May 2024
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; International Foundation for Dermatology, London, United Kingdom; Medical Practice Evaluation Foundation, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:
Ann Oncol
February 2024
Regeneron Pharmaceuticals, Inc., Tarrytown, USA.
Background: Metastatic basal cell carcinoma (mBCC) is a rare condition with no effective second-line treatment options. Cemiplimab is an immune checkpoint inhibitor that blocks the binding of programmed cell death-1 (PD-1) to its ligands, programmed death-ligand 1 (PD-L1) and programmed death-ligand 2 (PD-L2). Here, we present the final analysis of cemiplimab in patients with mBCC after first-line hedgehog pathway inhibitor (HHI) treatment (NCT03132636).
View Article and Find Full Text PDFSkin Appendage Disord
December 2023
2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, "Attikon" General University Hospital, Athens, Greece.
Introduction: Treatment of hidradenitis suppurativa (HS) is challenging, and in Hurley stage I, it is based on topical measures. Our aim was to compare the efficacy and safety of topical resorcinol 10% with topical clindamycin 1% and no therapy, in Hurley stage I HS.
Methods: In this open, prospective, randomized trial, we studied 60 Hurley stage I patients with IHS4 ≤10.
Dermatol Surg
March 2024
1st Department of Dermatology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Dermatol Ther (Heidelb)
December 2023
Dermatology Department, University Hospital of Heraklion, 71110, Heraklion, Crete, Greece.
Introduction: The basophil activation test (BAT) is a flow cytometry laboratory technique that assesses the level of activation indicators expressed on the surface of basophils. We conducted a real-life study in a prospective cohort of patients with reported drug hypersensitivity reactions to determine the true relevance of BAT as a diagnostic tool for assessing immediate hypersensitivity reactions to medicines.
Methods: We prospectively assessed individuals with clinical suspicion of immediate hypersensitivity reactions to drugs over a 2-year period.
Dermatol Pract Concept
October 2023
Service de Dermatologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France; Université Claude-Bernard-Lyon Lyon, Lyon, France and Lyons cancer research center UMR INSERM U1052 - CNRS5286 - UCBL1 Lyon France.
Melanonychia striata longitudinalis might involve one or more fingers and/or toes and might result from several different causes, including benign and malignant tumors, trauma, infections, and activation of melanocytes that might be reactive or related to the pigmentary trait, drugs and some rare syndromes. This broad differential diagnosis renders the clinical assessment of melanonychia striata particularly challenging. Nail matrix melanoma is relatively rare, occurs almost always in adults involves more frequently the first toe or thumb.
View Article and Find Full Text PDFDermatol Pract Concept
October 2023
Skin Cancer and Melanoma Unit, 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.
Dermatol Clin
January 2024
Chemical Peeling Department, Andreas Sygros Hospital of Dermatological and Venereal Diseases, University Clinic, National and Kapodistrian University, 5, Dragoumi street, Athens, Greece.
Chemical peeling is a procedure used for cosmetic improvement of the skin or treatment of some medical skin disorders, by the application of chemical exfoliant. In spite of a long history of clinical use of chemical peels, understanding of the science behind the procedure is still evolving. In this article, we review new concepts, understandings, and publications in the field of chemical peels.
View Article and Find Full Text PDFBr J Dermatol
January 2024
Skin Cancer and Melanoma Unit, 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens , Greece.
Australas J Dermatol
February 2024
Faculty of Medicine, 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.
Background/objectives: To date, scientific data on the efficacy of botulinum toxin type A (BoNT-A) for primary plantar hyperhidrosis (PPH) are mainly derived from case reports and small case series. Herein, we sought to assess the efficacy and safety of BoNT-A for PPH on a large series of patients.
Methods: Medical records of patients who were referred to the outpatient department for hyperhidrosis of a tertiary care hospital and received BoNT-A for PPH from March 2003 until December 2022 were reviewed.
J Eur Acad Dermatol Venereol
March 2024
Dermatology Department, University Hospital of Heraklion, Crete, Greece.
J Am Acad Dermatol
February 2024
Department of Dermatology, Hospital Clínic de Barcelona, FRCB, Universitat de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain. Electronic address:
J Am Acad Dermatol
February 2024
Regeneron Pharmaceuticals, Inc, Tarrytown, New York.
BMJ
October 2023
First Department of Dermatology-Venereology, Medical School, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.
Life (Basel)
August 2023
1st Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, 16121 Athens, Greece.
Eur J Cancer
November 2023
Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK.
Eur J Cancer
November 2023
Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK.
J Eur Acad Dermatol Venereol
January 2024
Faculty of Medicine, First Department of Dermatology-Venereology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Background: Subungual melanoma (SUM) is a rare type of cutaneous malignant melanoma (CMM) associated with poor prognosis, while data regarding its prevalence are scarce.
Objectives: We sought to provide a comprehensive systematic review and meta-analysis of the prevalence rates of SUM among all types of CMM, considering certain demographic and clinical characteristics.
Methods: The MEDLINE electronic database was searched systematically to identify eligible studies providing prevalence rate estimates of SUM in patients with CMM.
J Eur Acad Dermatol Venereol
January 2024
Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
Background: Acne fulminans (AF) is a rare severe acne entity. Although occasionally reported, it is unclear whether AF development is associated with oral isotretinoin treatment.
Objectives: To investigate the occurrence of isotretinoin-associated AF, clinical characteristics and prognosis at follow-up.
Nat Commun
August 2023
School of Cancer Sciences, University of Glasgow, Glasgow, G61 1QH, UK.